Improving the Therapeutic Index of Proinflammatory Cytokines for Cancer Immunotherapy Werewolf Therapeutics, Inc., is an ...

Melanoma is one of the most aggressive forms of skin cancer, arising from pigment-producing cells called melanocytes. While ...

These fungi activate the host complement system (such as the MBL ... For example, symbiotic fungi regulate the immune response in the tumor microenvironment by regulating the function of dendritic ...

BDC-3042 Phase 1 dose-escalation data presented at AACR 2025 demonstrated a favorable safety profile, dose-dependent ...

During the second half of 2025, Werewolf plans to present interim data from the monotherapy and combination expansion arms, including tolerability, response rate, and durability, and to engage with ...

WTX-124 Phase 1/1b clinical trial on track for data readouts and interactions with the FDA in the second half of the year - - First patient dosed in the Phase 1b/2 clinical trial of WTX-330, seeking ...

The leading Merkel Cell Carcinoma Companies such as ImmunityBio, OncoSec Medical, Exelixis, 4SC, Kartos Therapeutics, Incyte ...

This Research Topic is the third volume of the “Biomarkers in the era of cancer immunotherapy: zooming in from periphery to tumor microenvironment” Community Series. Please see Volume I here and ...

Ubiquitination, an essential post-translational modification, controls various cellular functions by attaching ubiquitin to proteins, dictating their fate from degradation to functional reorganization ...

The immune system can work in two ways: the innate immune system reacts to any foreign invaders that are identified by immune cells that look... | Cell And Molecular Biology ...

Discovery of innate immune receptor "brake" Siglec-E offers a novel therapeutic target to prevent organ transplant rejection ...